Steven M Swanson
Overview
Explore the profile of Steven M Swanson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
1738
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swanson S, Birnbaum A, Brackett C, Lipscomb J, Moniri N, Swaan P, et al.
Am J Pharm Educ
. 2023 Jul;
87(8):100556.
PMID: 37442437
No abstract available.
2.
Marker P, Unterberger C, Swanson S
Endocr Relat Cancer
. 2023 Feb;
30(5).
PMID: 36826838
Interest in investigating the role of the growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis in the initiation and progression of experimentally induced carcinomas has arisen due to several observations...
3.
Unterberger C, Mcilwain S, Tsourkas P, Maklakova V, Prince J, Onesti A, et al.
Prostate
. 2022 Dec;
83(5):416-429.
PMID: 36562110
Background: Humans with inactivating mutations in growth hormone receptor (GHR) have lower rates of cancer, including prostate cancer. Similarly, mice with inactivating Ghr mutations are protected from prostatic intraepithelial neoplasia...
4.
Unterberger C, McGregor S, Kopchick J, Swanson S, Marker P
Endocrinology
. 2022 Oct;
164(2).
PMID: 36269749
Female SV40 C3(1) T-antigen (C3(1)/TAg) transgenic mice develop mammary tumors that are molecularly similar to human basal-like breast cancers with 100% incidence at 16 weeks of age. To determine the...
5.
Unterberger C, Maklakova V, Lazar M, Arneson P, Mcilwain S, Tsourkas P, et al.
Endocrinology
. 2022 Apr;
163(5).
PMID: 35383352
Previous studies investigating the effects of blocking the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis in prostate cancer found no effects of the growth hormone receptor (GHR) antagonist, pegvisomant, on...
6.
Repp L, Unterberger C, Ye Z, Feltenberger J, Swanson S, Marker P, et al.
Nanomaterials (Basel)
. 2021 Oct;
11(10).
PMID: 34685195
Docetaxel (DTX) is among the most frequently prescribed chemotherapy drugs and has recently been shown to extend survival in advanced prostate cancer patients. However, the poor water solubility of DTX...
7.
Lantvit D, Unterberger C, Lazar M, Arneson P, Longhurst C, Swanson S, et al.
Endocrinology
. 2021 Jan;
162(4).
PMID: 33475144
Previously, we reported that N-methyl-N-nitrosourea (MNU)-induced mammary tumors could be established in mutant spontaneous dwarf rats (SDRs), which lack endogenous growth hormone (GH) by supplementing with exogenous GH, and almost...
8.
Wegner K, Mueller B, Unterberger C, Avila E, Ruetten H, Turco A, et al.
J Pathol
. 2019 Nov;
250(2):231-242.
PMID: 31674011
We genetically engineered expression of an activated form of P110 alpha, the catalytic subunit of PI3K, in mouse prostate epithelium to create a mouse model of direct PI3K activation (Pbsn-cre4Prb;PI3K...
9.
Madueke I, Hu W, Hu D, Swanson S, Vander Griend D, Abern M, et al.
Prostate
. 2019 Aug;
79(14):1692-1704.
PMID: 31433503
Background: WNT signaling is implicated in embryonic development, and in adult tissue homeostasis, while its deregulation is evident in disease. This study investigates the unique roles of canonical WNT10B in...
10.
Ren Y, de Blanco E, Fuchs J, Soejarto D, Burdette J, Swanson S, et al.
J Nat Prod
. 2019 Mar;
82(3):657-679.
PMID: 30830783
Higher plants are well known for their value in affording clinically useful anticancer agents, with such compounds acting against cancer cells by a range of mechanisms of action. There remains...